Guggenheim initiated coverage of Assembly Biosciences (ASMB) with a Buy rating and $31 price target
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.